Quick Answer
UTAH MEDICAL PRODUCTS INC reported Research And Development Expense of $668.0 thousand for the year ending 2025.
- UTAH MEDICAL PRODUCTS INC showed a decrease of -17.8% in Research And Development Expense from 2024 to 2025.
- This data is from UTAH MEDICAL PRODUCTS INC's annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), UTAH MEDICAL PRODUCTS INC's Research And Development Expense has grown by 85.0%.
- Historical annual values: Fiscal year 2025: $668.0 thousand | Fiscal year 2024: $813.0 thousand | Fiscal year 2023: $560.0 thousand | Fiscal year 2022: $493.0 thousand | Fiscal year 2021: $526.0 thousand | Fiscal year 2020: $486.0 thousand | Fiscal year 2019: $483.0 thousand | Fiscal year 2018: $454.0 thousand | Fiscal year 2017: $447.0 thousand | Fiscal year 2016: $475.0 thousand | Fiscal year 2015: $522.0 thousand | Fiscal year 2014: $460.0 thousand | Fiscal year 2013: $491.0 thousand | Fiscal year 2012: $563.0 thousand | Fiscal year 2011: -$518.0 thousand | Fiscal year 2010: $397.0 thousand | Fiscal year 2009: $361.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: